NCT02641899View on ClinicalTrials.gov

Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Healthy
Interventions
DRUG

ITCA 650 20/60 mcg/day

ITCA 650 osmotic mini pump delivering exenatide 20 mcg/day for 14 days, followed by ITCA 650 osmotic mini pump delivering exenatide 60 mcg/day.

DRUG

Acetaminophen

Oral acetaminophen 1000 mg on Day 1 and Day 27

DRUG

Atorvastatin

Oral atorvastatin 40 mg on Day 2 and Day 28

DRUG

Lisinopril

Oral lisinopril 20 mg on Day 2 and Day 28

DRUG

Warfarin

Oral warfarin 25 mg on Day 2 and Day 28

DRUG

Digoxin

Oral digoxin 0.5 mg on Day 2 and Day 28

Trial Locations (1)

66211

Quintiles, Overland Park

Sponsors
All Listed Sponsors
lead

Intarcia Therapeutics

INDUSTRY